B7.1 and B7.2 mean fluorescence intensity in human monocytes
. | t0 . | Us . | LPS . | +CGRP8-37 . | +IgG . | +abNGF . |
|---|---|---|---|---|---|---|
| CD80 | — | 1.5 ± 0.4 | 3.4 ± 0.6 | 2.8 ± 0.5 | 3.2 ± 0.4 | 2.9 ± 0.5 |
| CD86 | 2.9 ± 0.7 | 9.8 ± 0.6 | 3.8 ± 0.8 | 6.7 ± 0.7* | 4.3 ± 0.5 | 7.4 ± 0.6* |
. | t0 . | Us . | LPS . | +CGRP8-37 . | +IgG . | +abNGF . |
|---|---|---|---|---|---|---|
| CD80 | — | 1.5 ± 0.4 | 3.4 ± 0.6 | 2.8 ± 0.5 | 3.2 ± 0.4 | 2.9 ± 0.5 |
| CD86 | 2.9 ± 0.7 | 9.8 ± 0.6 | 3.8 ± 0.8 | 6.7 ± 0.7* | 4.3 ± 0.5 | 7.4 ± 0.6* |
The results are expressed as increments relative to the controls of mean fluorescence intensity plus or minus standard error of the mean (ΔMFI ± SEM).
— indicates not detectable.
LPS+CGRP8-37 vs LPS, and LPS+aNGF vs LPS+IgG: P < .05 according to Tukey-Kramer test